(Q34431275)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218527%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218527%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218527%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

G Edan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218527%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

L Kappos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218527%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

C H Polman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218527%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

M S Freedman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218527%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

H-P Hartung

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218527%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

D Miller

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218527%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

F Barkhof

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218527%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

J Herrmann

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218527%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

V Lanius

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218527%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

B Stemper

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218527%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

C Pohl

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218527%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

R Sandbrink

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218527%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

D Pleimes

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218527%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

BENEFIT Study Group

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218527%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

English

0 references

publication date

11 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218527%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neurology, Neurosurgery and Psychiatry

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218527%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218527%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218527%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

1183-1189

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218527%20AND%20SRC:MED&resulttype=core&format=json

Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis

29 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4215285

The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4215285

Evidence for a two-stage disability progression in multiple sclerosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4215285

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4215285

Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4215285

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4215285

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4215285

Development of a multiple sclerosis functional composite as a clinical trial outcome measure

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4215285

EuroQol--a new facility for the measurement of health-related quality of life

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4215285

Validation of the functional assessment of multiple sclerosis quality of life instrument

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4215285

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4215285

Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study.

6 July 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306222

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306222

Interferon β-1b-neutralizing antibodies 5 years after clinically isolated syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306222

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306222

IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24218527

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24218527

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24218527

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/JNNP-2013-306222

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218527%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218527%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

PubMed publication ID

24218527

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24218527%20AND%20SRC:MED&resulttype=core&format=json